These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease. Baker KB; Spurrier NJ; Watkins AS; Smith JR; Rosenbaum JT Br J Ophthalmol; 2006 Dec; 90(12):1481-5. PubMed ID: 16914474 [TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil for the treatment of uveitis. Teoh SC; Hogan AC; Dick AD; Lee RW Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143 [TBL] [Abstract][Full Text] [Related]
11. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Simonini G; Paudyal P; Jones GT; Cimaz R; Macfarlane GJ Rheumatology (Oxford); 2013 May; 52(5):825-31. PubMed ID: 22879466 [TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil in the treatment of uveitis in children. Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275 [TBL] [Abstract][Full Text] [Related]
13. [Eye and corticosteroid's use]. Fel A; Aslangul E; Le Jeunne C Presse Med; 2012 Apr; 41(4):414-21. PubMed ID: 22377461 [TBL] [Abstract][Full Text] [Related]
14. [TNFalpha inhibitors in the treatment of uveitis]. Greiner K; Plskova J Ophthalmologe; 2005 Apr; 102(4):335-40. PubMed ID: 15690162 [TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Therapy in Uveitis. Tomkins-Netzer O; Talat L; Ismetova F; Samy A; Lightman S Dev Ophthalmol; 2016; 55():265-75. PubMed ID: 26501368 [TBL] [Abstract][Full Text] [Related]
16. [Immunosuppressive therapy of uveitis with corticosteroids and cytostatic drugs]. Fekete B; Szegedi G; Szabó G; Petrányi G; Bauer N; Gát L Orv Hetil; 1972 Aug; 113(34):2036-41. PubMed ID: 5051435 [No Abstract] [Full Text] [Related]
17. New Immunosuppressive Therapies in Uveitis Treatment. Mérida S; Palacios E; Navea A; Bosch-Morell F Int J Mol Sci; 2015 Aug; 16(8):18778-95. PubMed ID: 26270662 [TBL] [Abstract][Full Text] [Related]
18. Side-effects of anti-inflammatory therapy in uveitis. Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874 [TBL] [Abstract][Full Text] [Related]
19. TNF inhibition for ophthalmic indications: current status and outlook. Rifkin LM; Birnbaum AD; Goldstein DA BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177 [TBL] [Abstract][Full Text] [Related]
20. [Immunologic mechanisms and the effect of immunosuppressive therapy in ophthalmology]. Poch T; Ríhová E; Michalová K Cesk Oftalmol; 1993 Jun; 49(3):131-8. PubMed ID: 8348646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]